ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag new york city disease medicine neuroscience immunology

Blue T cell with other blurred T cells in the background
Woman Seemingly Cured of HIV After Umbilical Cord Transplant
Natalia Mesa, PhD | Feb 16, 2022 | 3 min read
Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.
3D image of a neuron cell network with a red glow representing inflammation.
New Insight into Brain Inflammation Inspires New Hope for Epilepsy Treatment 
Deanna MacNeil, PhD | Jun 1, 2023 | 2 min read
Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.
NEW York-New Jersey Life Science Nirvana
Ted Agres | Apr 11, 2004 | 7 min read
Love it or hate it, if you want to play in the big leagues, the New York-New Jersey region is the place to be. From prestigous universities, medical centers, and research hospitals in Manhattan and Long Island, to major pharmaceutical research and manufacturing facilities in New Jersey, the region's life sciences can be characterized by such words as power-house and blockbuster.New York City alone (Manhattan, Brooklyn, Queens, Staten Island, and the Bronx) boasts 25 academic research and medical
The balance of mind and body on a seesaw
Psychological Stress Distracts the Immune System from Fighting Infections
Jennifer Zieba, PhD | Aug 8, 2022 | 3 min read
Acute stress makes immune cells migrate immediately to the bone marrow, which prepares the body for injury at the expense of increasing infectious disease susceptibility.
Immunology and Neurology Pioneer Dies
Rina Shaikh-Lesko | May 23, 2014 | 1 min read
Gerald Edelman, who broke new ground in two distinct fields of life science, has passed away at age 84.
Woman in face shield and blue gown taking cotton swab of patient's mouth while patient sits inside of car
What You Should Know About New Omicron Subvariants
Natalia Mesa, PhD | May 17, 2022 | 6 min read
The presence and spread of new, more-infectious and immune-evading variants show that the coronavirus is not done mutating.
Sponsor Profile: Biotech and the City
The Scientist Staff | Nov 21, 2004 | 4 min read
ImClone Systems began its history as a New York company in 1984 when its founders, an immunologist and a pathologist both living and working in the city, set out to meld the established and respected world of New York City academia with the dynamic and fledgling biotechnology industry.
Panels showing different kinds of microglia
Mapping Tool Reveals Microglia’s Shape-Shifting Secrets
Angie Voyles Askham, Spectrum | Dec 14, 2022 | 4 min read
The approach could help test hypotheses about how atypical function of the brain’s immune cells contributes to autism.
Do Microbes Trigger Alzheimer’s Disease?
Jill U. Adams | Sep 1, 2017 | 10 min read
The once fringe idea is gaining traction among the scientific community.
New companies to commercialise neuroscience discoveries
John Borchardt | Nov 2, 2000 | 4 min read
Neurogenomics has significant commercial potential by way of gene targets for enhancement of brain function and treatment of brain-based disease.

Run a Search

ADVERTISEMENT